Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
6.01
-0.30 (-4.75%)
At close: Oct 16, 2026, 4:00 PM EDT
6.00
-0.01 (-0.17%)
After-hours: Oct 16, 2026, 7:30 PM EDT
Profound Medical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Profound Medical stock has a consensus rating of "Strong Buy" and an average price target of $11.14. The average 1-year stock price forecast is 85.36% higher than the current stock price, while the lowest is $10 (+66.39%) and the highest is $12 (+99.67%).
Price Target: $11.14 (+85.36%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Sep 11, 2026.
Analyst Ratings
The average analyst rating for Profound Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Titan Partners No rating | Titan Partners | Buy Initiates $12 | Buy | Initiates | $12 | +99.67% | Sep 11, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $10 | Buy | Maintains | $10 | +66.39% | Aug 7, 2026 |
| Lake Street | Lake Street | Buy Reiterates $12 | Buy | Reiterates | $12 | +99.67% | Aug 7, 2026 |
| Raymond James | Raymond James | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 7, 2026 |
Financial Forecast
Revenue This Year
27.54M
from 16.10M
Increased by 71.10%
Revenue Next Year
43.67M
from 27.54M
Increased by 58.54%
EPS This Year
-0.86
from -1.41
EPS Next Year
-0.60
from -0.86
EPS and Forward PE are based on non-GAAP adjusted numbers.